Glenmark Pharma Shares Rise

Glenmark Pharma Shares up by 35% | Biggest Intraday Rise

In Monday trade, Glenmark Pharma shares saw a spout of 35 per cent after announcing launching an antiviral drug Favipiravir, under FabiFlu brand name on Saturday to treat mild to moderate Covid-19 patients at Rs. 103 per tablet. The company said in a regulatory filing,” The drugs would come in a strip of 34 tablets with…